Proactive Investors
23 Oct 2026, 10:45 UTC · 1h ago
Petra Diamonds shares fall 26% as audit delay puts trading suspension on the cards
Impact · against what's priced in
Petra Diamonds faces a severe liquidity and governance crisis with an imminent trading suspension, making it a high-risk asset. Ondine Biomedical gains clinical validation for Steriwave, while Bezant Resources marginally improves its liquidity position.
- PDL−0.90
No priced-in read yet
- In context
The expected trading suspension on November 2 and the failure to meet the October 31 annual report deadline create total illiquidity and potential credit defaults.
Read from the article alone
